Development and Validation of a clinical scale for defining RBD severity in participants of the North American Prodromal Synucleinopathy (NAPS) consortium

enthalten in: Alzheimer's & Dementia | 2022

von Choudhury, P. | Busicescu, A. | Lee‐Iannotti, J. | +5